Ansun BioPharma Revenue and Competitors
Estimated Revenue & Valuation
- Ansun BioPharma's estimated annual revenue is currently $5.7M per year.
- Ansun BioPharma's estimated revenue per employee is $155,000
Employee Data
- Ansun BioPharma has 37 Employees.
- Ansun BioPharma grew their employee count by 6% last year.
Ansun BioPharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP CMC | Reveal Email/Phone |
Ansun BioPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ansun BioPharma?
Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics. Our lead product, DAS181, is a multi-function sialidase fusion protein for host-cellprotection in respiratory virus infection, including parainfluenza, influenza and COVID19,. We are also advancing several additional programs in oncology and autoimmune diseases using our sialidase platform technology.
keywords:N/A
N/A
Total Funding
37
Number of Employees
$5.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.3M | 37 | 6% | N/A |
#2 | $3.9M | 37 | -36% | $141M |
#3 | $7.2M | 37 | -14% | N/A |
#4 | $4.3M | 37 | 23% | N/A |
#5 | $7.4M | 37 | 9% | N/A |